{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:54:29Z","timestamp":1773708869030,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.carrev.2022.07.018","type":"journal-article","created":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T20:54:10Z","timestamp":1658868850000},"page":"67-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["One-Year Follow-Up of Vascular Intervention Trials Disrupted by the COVID-19 Pandemic: A Use-Case landscape"],"prefix":"10.1016","volume":"45","author":[{"given":"Jennifer A.","family":"Rymer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay J.","family":"Kirtane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Farb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misti","family":"Malone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Jaff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirk","family":"Seward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark K.","family":"Barakat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell W.","family":"Krucoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2022.07.018_bb0005","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/d41573-020-00150-9","article-title":"Clinical trial recovery from COVID-19 disruption","volume":"19","author":"Xue","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.carrev.2022.07.018_bb0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/CIRCULATIONAHA.117.033502","article-title":"2017 cardiovascular and stroke endpoint definitions for clinical trials","volume":"137","author":"Hicks","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2022.07.018_bb0020","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.121.011320","article-title":"Patient-reported outcome measures in symptomatic, non-limb threatening peripheral artery disease: a state-of-the-art review","volume":"15","author":"Rymer","year":"2022","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2022.07.018_bb0025","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.005285","article-title":"Two decades of cardiovascular trials with primary surrogate endpoints: 1990\u20132011","volume":"6","author":"Bikdeli","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.carrev.2022.07.018_bb0030","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1016\/j.jacc.2020.09.544","article-title":"Conduct of clinical trials in the era of COVID-19: JACC scientific expert panel","volume":"76","author":"Psotka","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2022.07.018_bb0035","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.carrev.2022.07.018_bb0040","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.jacc.2021.02.055","article-title":"Society for Cardiac Angiography and Interventions, the Canadian Association of Interventional Cardiology, and the American College of Cardiology Interventional Council. Initial findings from the North American COVID\u201319 myocardial infarction registry","volume":"77","author":"Garcia","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2022.07.018_bb0045","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.atherosclerosis.2021.06.926","article-title":"Impact of SARS\u2013CoV\u20132 positivity on clinical outcome among STEMI patients undergoing mechanical reperfusion: insights from the ISACS STEMI COVID 19 Registry","volume":"332","author":"De Luca","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.carrev.2022.07.018_bb0050","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1001\/jama.2021.18890","article-title":"Association between COVID-19 diagnosis and in-hospital mortality in patients hospitalized with ST-segment elevation myocardial infarction","volume":"326","author":"Saad","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2022.07.018_bb0055","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2021-001600","article-title":"Lockdown, slow down: impact of the COVID-19 pandemic on physical activity\u2014an observational study","volume":"8","author":"Taylor","year":"2021","journal-title":"Open Heart"},{"key":"10.1016\/j.carrev.2022.07.018_bb0060","first-page":"423","article-title":"Heart failure collaboratory statement on clinical trials in the landscape of COVID-19. JACC","volume":"8","author":"Abraham","year":"2020","journal-title":"Heart Failure"},{"key":"10.1016\/j.carrev.2022.07.018_bb0065","first-page":"65","article-title":"Clinical outcomes in patients with heart failure hospitalized with COVID-19","volume":"9","author":"Bhatt","year":"2021","journal-title":"J Am Coll Cardiol HF"},{"issue":"11","key":"10.1016\/j.carrev.2022.07.018_bb0070","first-page":"1000","article-title":"\u201cCollaborative communities\u201d tackle device development challenges","volume":"326","author":"Kuehn","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2022.07.018_bb0075","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ahj.2015.07.029","article-title":"Predictable and SuStainable implementation of National Cardiovascular Registries (PASSION) infrastructure: a think tank report from medical device epidemiological network initiative (MDEpiNet)","volume":"171","author":"Zeitler","year":"2016","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2022.07.018_bb0080","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/jama.2016.8708","article-title":"Need for a National Evaluation System for health technology","volume":"316","author":"Shuren","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2022.07.018_bb0085","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1001\/jama.2015.11036","article-title":"Bridging unmet medical device ecosystem needs with strategically coordinated registries networks","volume":"27","author":"Krucoff","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2022.07.018_bb0095","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ahj.2019.09.014","article-title":"Opportunities for enhancing the care of older patients with ST-elevation myocardial infarction presenting for primary percutaneous coronary intervention: rationale and design of the SAFE-STEMI for seniors trial","volume":"218","author":"Rymer","year":"2019","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2022.07.018_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2022.03.003","article-title":"Randomized evaluation of vessel preparation with orbital atherectomy prior to drug-eluting stent implantation in severely calcified coronary artery lesions. Design and rationale of the ECLIPSE trial","volume":"249","author":"G\u00e9n\u00e9reux","year":"2022","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2022.07.018_bb0105","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1161\/CIRCULATIONAHA.120.052482","article-title":"Novel SupremeTM DES with early synchronized antiproliferative drug delivery to inhibit smooth muscle cell proliferation after DES implantation in coronary artery disease: results of the PIONEER III randomized clinical trial","volume":"143","author":"Lansky","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2022.07.018_bb0115","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/j.tvir.2014.08.012","article-title":"The BEST-CLI trial: a multidisciplinary effort to assess which therapy is best for patients with critical limb ischemia","volume":"17","author":"Farber","year":"2014","journal-title":"Tech Vasc Interv Radiol"},{"key":"10.1016\/j.carrev.2022.07.018_bb0135","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s13063-021-05219-3","article-title":"The COVID-19 pandemic and new clinical trial activations","volume":"22","author":"Unger","year":"2021","journal-title":"Trials"},{"key":"10.1016\/j.carrev.2022.07.018_bb0140","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1053\/j.semvascsurg.2021.04.001","article-title":"The impact of COVID-19 pandemic on vascular registries and clinical trials","volume":"34","author":"Aziz","year":"2021","journal-title":"Semin Vasc Surg"},{"key":"10.1016\/j.carrev.2022.07.018_bb0145","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13063-020-05004-8","article-title":"Managing clinical trials during COVID-19: experience from a clinical research facility","volume":"22","author":"Shiely","year":"2021","journal-title":"Trials"},{"key":"10.1016\/j.carrev.2022.07.018_bb0155","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/neurintsurg-2020-016502","article-title":"Neuroendovascular clinical trials disruptions due to COVID-19. Potential future challenges and opportunities","volume":"12","author":"Rai","year":"2020","journal-title":"J Neurointerventional Surg"},{"key":"10.1016\/j.carrev.2022.07.018_bb0160","series-title":"Sustainable resumption of cardiac catheterization laboratory procedures, and the importance of testing, during endemic COVID-19 current treatment options in cardiovascular medicine","first-page":"23","author":"Zaman","year":"2021"},{"issue":"19","key":"10.1016\/j.carrev.2022.07.018_bb0170","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1001\/jama.2021.4609","article-title":"Remote research and clinical trial integrity during and after the coronavirus pandemic","volume":"325","author":"McDermott","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2022.07.018_bb0185","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/eurheartj\/ehaa461","article-title":"Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an expert consensus position paper from the heart failure association (HFA) of the european Society of Cardiology (ESC)","volume":"41","author":"Anker","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2022.07.018_bb0190","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1161\/CIRCULATIONAHA.120.047457","article-title":"Population trends in rates of percutaneous coronary revascularization for acute coronary syndromes associated with the COVID-19 outbreak","volume":"141","author":"Piccolo","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2022.07.018_bb0195","doi-asserted-by":"crossref","first-page":"458","DOI":"10.15585\/mmwr.mm6915e3","article-title":"Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 - COVID-NET, 14 states, march 1\u201330, 2020","volume":"69","author":"Garg","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.carrev.2022.07.018_bb0200","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41591-022-01689-3","article-title":"Long-term cardiovascular outcomes of COVID-19","volume":"28","author":"Xie","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.carrev.2022.07.018_bb0205","doi-asserted-by":"crossref","first-page":"517","DOI":"10.15585\/mmwr.mm7114e1","article-title":"Cardiac complications after SARS-CoV-2 infection and mRNA COVID-19 vaccination \u2014 PCORnet, United States, january 2021\u2013January 2022","volume":"71","author":"Block","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838922006881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838922006881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:24:42Z","timestamp":1761560682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838922006881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":31,"alternative-id":["S1553838922006881"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2022.07.018","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"One-Year Follow-Up of Vascular Intervention Trials Disrupted by the COVID-19 Pandemic: A Use-Case landscape","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2022.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}